These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33376202)

  • 1. Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
    Ostkamp P; Salmen A; Pignolet B; Görlich D; Andlauer TFM; Schulte-Mecklenbeck A; Gonzalez-Escamilla G; Bucciarelli F; Gennero I; Breuer J; Antony G; Schneider-Hohendorf T; Mykicki N; Bayas A; Then Bergh F; Bittner S; Hartung HP; Friese MA; Linker RA; Luessi F; Lehmann-Horn K; Mühlau M; Paul F; Stangel M; Tackenberg B; Tumani H; Warnke C; Weber F; Wildemann B; Zettl UK; Ziemann U; Müller-Myhsok B; Kümpfel T; Klotz L; Meuth SG; Zipp F; Hemmer B; Hohlfeld R; Brassat D; Gold R; Gross CC; Lukas C; Groppa S; Loser K; Wiendl H; Schwab N;
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33376202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis.
    Dwyer T; van der Mei I; Ponsonby AL; Taylor BV; Stankovich J; McKay JD; Thomson RJ; Polanowski AM; Dickinson JL
    Neurology; 2008 Aug; 71(8):583-9. PubMed ID: 18711112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.
    Jelinek GA; Marck CH; Weiland TJ; Pereira N; van der Meer DM; Hadgkiss EJ
    BMC Neurol; 2015 Aug; 15():132. PubMed ID: 26243188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
    Stewart N; Simpson S; van der Mei I; Ponsonby AL; Blizzard L; Dwyer T; Pittas F; Eyles D; Ko P; Taylor BV
    Neurology; 2012 Jul; 79(3):254-60. PubMed ID: 22700816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating effects of WT1 on interferon-β-vitamin D association in MS.
    Lin R; Taylor BV; Charlesworth J; van der Mei I; Blizzard L; Stewart N; Ponsonby AL; Dwyer T; Pittas F; Simpson S
    Acta Neurol Scand; 2015 Apr; 131(4):231-9. PubMed ID: 25312909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sun exposure and vitamin D are independent risk factors for CNS demyelination.
    Lucas RM; Ponsonby AL; Dear K; Valery PC; Pender MP; Taylor BV; Kilpatrick TJ; Dwyer T; Coulthard A; Chapman C; van der Mei I; Williams D; McMichael AJ
    Neurology; 2011 Feb; 76(6):540-8. PubMed ID: 21300969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental factors and multiple sclerosis severity: a descriptive study.
    Mandia D; Ferraro OE; Nosari G; Montomoli C; Zardini E; Bergamaschi R
    Int J Environ Res Public Health; 2014 Jun; 11(6):6417-32. PubMed ID: 24950063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.
    Vitkova M; Diouf I; Malpas C; Horakova D; Kubala Havrdova E; Patti F; Ozakbas S; Izquierdo G; Eichau S; Shaygannejad V; Onofrj M; Lugaresi A; Alroughani R; Prat A; Larochelle C; Girard M; Duquette P; Terzi M; Boz C; Grand'Maison F; Sola P; Ferraro D; Grammond P; Butzkueven H; Buzzard K; Skibina O; Yamout BI; Karabudak R; Gerlach O; Lechner-Scott J; Maimone D; Bergamaschi R; Van Pesch V; Iuliano G; Cartechini E; José Sà M; Ampapa R; Barnett M; Hughes SE; Ramo-Tello CM; Hodgkinson S; Spitaleri DLA; Petersen T; Butler EG; Slee M; McGuigan C; McCombe PA; Granella F; Cristiano E; Prevost J; Taylor BV; Sãnchez-Menoyo JL; Laureys G; Van Hijfte L; Vucic S; Macdonell RA; Gray O; Olascoaga J; Deri N; Fragoso YD; Shaw C; Kalincik T;
    Neurology; 2022 Jun; 98(24):e2401-e2412. PubMed ID: 35410900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis.
    Knippenberg S; Damoiseaux J; Bol Y; Hupperts R; Taylor BV; Ponsonby AL; Dwyer T; Simpson S; van der Mei IA
    Acta Neurol Scand; 2014 Feb; 129(2):123-31. PubMed ID: 23763464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.
    Zivadinov R; Treu CN; Weinstock-Guttman B; Turner C; Bergsland N; O'Connor K; Dwyer MG; Carl E; Ramasamy DP; Qu J; Ramanathan M
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1075-81. PubMed ID: 23385850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.
    Soilu-Hänninen M; Aivo J; Lindström BM; Elovaara I; Sumelahti ML; Färkkilä M; Tienari P; Atula S; Sarasoja T; Herrala L; Keskinarkaus I; Kruger J; Kallio T; Rocca MA; Filippi M
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):565-71. PubMed ID: 22362918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis.
    Royal W; Mia Y; Li H; Naunton K
    J Neuroimmunol; 2009 Aug; 213(1-2):135-41. PubMed ID: 19539379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
    Mix E; Stefan K; Höppner J; Klauer T; Zettl UK; Strauss U; Meyer-Rienecker HJ; Rolfs A
    Autoimmunity; 2003 Aug; 36(5):291-305. PubMed ID: 14567559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.
    van der Mei IA; Ponsonby AL; Dwyer T; Blizzard L; Taylor BV; Kilpatrick T; Butzkueven H; McMichael AJ
    J Neurol; 2007 May; 254(5):581-90. PubMed ID: 17426912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; Garmyn M; De Keyser J
    Mult Scler; 2012 Apr; 18(4):451-9. PubMed ID: 21952096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sun exposure over the life course and associations with multiple sclerosis.
    Tremlett H; Zhu F; Ascherio A; Munger KL
    Neurology; 2018 Apr; 90(14):e1191-e1199. PubMed ID: 29514944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D in African Americans with multiple sclerosis.
    Gelfand JM; Cree BA; McElroy J; Oksenberg J; Green R; Mowry EM; Miller JW; Hauser SL; Green AJ
    Neurology; 2011 May; 76(21):1824-30. PubMed ID: 21606454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative study of the knowledge, behaviour and attitudes of patients with skin cancer regarding sunlight exposure and vitamin D.
    Rutkowski D; Farrar MD; Osman JE; Webb AR; Rhodes LE
    Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):203-208. PubMed ID: 28449308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low sun exposure increases multiple sclerosis risk both directly and indirectly.
    Hedström AK; Olsson T; Kockum I; Hillert J; Alfredsson L
    J Neurol; 2020 Apr; 267(4):1045-1052. PubMed ID: 31844981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.